LVCLF Stock - Algorae Pharmaceuticals Limited
Unlock GoAI Insights for LVCLF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | $125,200 | $42,016 | $3,405 | $268,184 |
| Gross Profit | N/A | $125,200 | $41,459 | $2,662 | $218,870 |
| Gross Margin | N/A | 100.0% | 98.7% | 78.2% | 81.6% |
| Operating Income | $-1,555,461 | $-2,077,632 | $-2,087,478 | $-2,384,955 | $-2,010,660 |
| Net Income | $-802,958 | $-2,095,562 | $-2,107,658 | $-1,957,300 | $-1,460,591 |
| Net Margin | N/A | -1673.8% | -5016.3% | -57483.1% | -544.6% |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer's disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the University of New South Wales, an artificial intelligence platform for biopharmaceutical prediction of both fixed dose combination drug targets and repurposed drug targets agnostic to medical indication. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.
Visit WebsiteEarnings History & Surprises
LVCLFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 24, 2026 | — | — | — | — |
Q3 2025 | Aug 28, 2025 | — | $-0.00 | — | — |
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Oct 22, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.00 | — | — |
Q4 2018 | Dec 30, 2018 | — | $-0.00 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.00 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.00 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about LVCLF
What is LVCLF's current stock price?
What is the analyst price target for LVCLF?
What sector is Algorae Pharmaceuticals Limited in?
What is LVCLF's market cap?
Does LVCLF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to LVCLF for comparison